Based on clinician feedback Medtronic’s third generation cryoballoon nudges ablative treatment of atrial fibrillation along
Cardio
Promise for Harpoon Medical’s MR System as it Enrols First Three Patients
It’s a simple concept. Hook the failing mitral valve leaflet and anchor it to the heart wall. Feasibility study suggests it might work too
New CEO and CFO for Direct Flow Medical®
High profile appointments come at an important time as the company drives EU sales and US pivotal study
FDA Cleared for U.S. Launch: Medtronic’s Euphora™ Semicompliant Coronary Balloon
Following on the heels of its non compliant forebear, the Euphora semicompliant coronary balloon offers enhanced pushability
Early CE Mark for STENTYS’ Next-Generation Self-Apposing Stent System
“Quantum Leap” in design means Self-Apposing stent delivery now mimics conventional stent placement, says the company
Sorin Enjoys Positive AATS Perceval Valve Presentations
Sorin’s sutureless aortic valve demonstrates improved outcome compared with TAVR in medium-high risk patients and favorable outcomes in every day surgery
Enova Illumination Launches World’s “Newest and Brightest” LED Surgical Headlight
Enova Illumination is celebrating its tenth anniversary and launching a new LED surgical headlight at the same time.
FDA Approval for Only ICD to Deliver Ultra-High Energy on First Shock
Delivering 42 Joules on first shock addresses patients with high defibrillation thresholds
First Patient in Tendyne’s U.S. Transcatheter Mitral Valve Replacement Trial
Clinical stage medical device company, Tendyne Holdings, Inc., tells us its Tendyne Bioprosthetic Mitral Valve was successfully implanted in a first patient in the United States
FDA OKs US Early Feasibility Study of CardiAQ™ Transcatheter Mitral Valve
The company is chasing a first transcatheter mitral valve approval in the United States and this new study is a step in the right direction
Direct Flow Trial Broadened to Include High Risk Patients and CoreValve® Comparison
FDA’s agreement to trial expansion should tell us whether novel valve design proves itself in competitive setting
Biotronik Launches “Workhorse” Pantera Pro Coronary Balloon Catheter in EU
Company says its new balloon is designed to enhance access to difficult lesions and challenging patient anatomies
Miracor Building Commercial Platform on Solid Clinical Foundations in the UK
The concept of increasing myocardial perfusion by intermittently blocking the coronary sinus in MI patients, looks promising
FDA Approves CoreValve for Valve-In-Valve Use, Expanding Treatment Options
CoreValve becomes first TAVR device to be indicated for replacement of failed surgical heart valves, expanding the patient population that can benefit from this minimally invasive procedure
FDA Approval for Impella 2.5 in Elective and Urgent High Risk PCI
With this approval, Impella 2.5 becomes the only FDA-approved percutaneous hemodynamic support device for high risk indications
FDA and CE Mark Approval for Boston Scientific’s Thinner S-ICD System
Boston Scientific will be hoping its new S-ICD will prove popular based on its advantages over conventionally placed leads